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With more than 350 million depressed individuals worldwide, major depressive disorder is one
of the most common psychiatric illnesses. Although, the pathophysiology of depression is far
from being fully understood, five decades of development of different classes of antidepressants
targeting central monoaminergic systems (serotonin, noradrenaline and dopamine) has led to the
emergence of the monoaminergic hypothesis. However, despite a growing number of available
pharmacotherapies, treatment of major depression nevertheless remains unsatisfactory.
ROLE OF GLIA IN THE PHYSIOPATHOLOGY OF DEPRESSION
AND THE MECHANISMS OF ACTION OF ANTIDEPRESSANTS
Ten years ago it was postulated that abnormal functioning of glial cells, particularly of astrocytes,
contribute to the physiopathology of depression (for review, Rajkowska andMiguel-Hidalgo, 2007).
Structural and functional abnormalities of glial cells were found in brains of post-mortem depressed
patients and in animal models of depression (Czéh et al., 2006, 2007; Banasr et al., 2007; Sun
et al., 2012). Moreover, it has been shown that a loss or a functional alteration of astrocytes in the
prefrontal cortex is sufficient to induce depressive-like behaviors in rodents (Banasr and Duman,
2008; Sun et al., 2012; Kong et al., 2014).
Given the intimate anatomical and functional relationships between astrocytes and neurons, a
tempting hypothesis has emerged proposing that the effects of antidepressant therapies can be, at
least in part, mediated by direct astrocytic modulations of neuronal networks. In support of this
idea, increasing experimental evidence suggests that antidepressants induce functional changes
in astrocytes (Czéh and Di Benedetto, 2012). In addition, it is becoming increasingly clear that
the astrocytic network is able to regulate neuronal activity and synaptic transmission through the
release of gliotransmitters at what is now called “the tripartite synapse” (Halassa and Haydon,
2010; Panatier et al., 2011). Astrocytes can be directly modulated by an antidepressant treatment or
indirectly activated by antidepressant-induced increases in neurotransmitter concentrations in the
synaptic cleft, leading to the activation of G protein–coupled receptors (including serotonergic,
adrenergic and dopaminergic receptors) on astrocyte membranes. Once “activated,” astrocytes
release gliotransmitters and modulate neuronal communication and antidepressant responses. The
concept of gliotransmission precisely refers to the process by which astrocytes release chemical
factors in the vicinity of synapses thus modulating the activity of neighboring cells (for review,
Volterra and Meldolesi, 2005; Santello et al., 2012). Although, a large number of such molecules
have already been identified (e.g., glutamate, ATP, D-serine, GABA, neurotrophins), our focus here
will be specifically on adenosine since it acts directly on the process of neuronal communication
and is implicated in pseudo-depressive-like behavior and antidepressant response.
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ATP is mainly considered as an excitatory transmitter
(Gordon et al., 2005) but it is also rapidly hydrolyzed into
adenosine by ectonucleotidases present in the synaptic cleft.
Adenosine acts as a powerful inhibitor of excitatory transmission
through the stimulation of adenosine A1 receptors (Newman,
2003; Pascual et al., 2005). Adenosine or adenosine agonists
induce depressive-like behaviors in two experimental paradigms,
namely inescapable shocks (Minor et al., 1994; Hunter et al.,
2003) and forced swimming tests (Kulkarni and Mehta, 1985;
Cao et al., 2013), an effect that can be prevented by specific
adenosine antagonists or antidepressants. Specific A2A receptor
antagonists also reverse synaptic changes induced by stress in
the hippocampus, which is considered as a preclinical marker
of antidepressant responses (Cunha et al., 2006). However, these
interpretations are further complicated by the findings observed
after selective manipulations of the adenosine A1 transmission.
Thus, central administration of an A1 receptor agonist mimics
the antidepressant effect of sleep deprivation, an effect absent
in A
−/−
1 KO mice (Hines et al., 2013). Sleep deprivation is
also associated with pronounced increases of adenosine levels
and an up-regulation of glial adenosine A1-receptors in the
brains of both depressed patients (Van Calker and Biber, 2005)
and rodents (Hines et al., 2013). The apparent discrepancy
between the “depressiogenic” influence of adenosine, and some
antidepressant-like actions of A1 agonists, could be due to the
complex modulation exerted by A1 receptors on axonal firing
that appears to depend on the degree of activity of the related
networks (see below).
ASTROCYTES ARE DEEPLY INVOLVED IN
THE NEUROBIOLOGICAL EFFECTS OF
DEEP BRAIN STIMULATION
As observed during pharmacological treatments, recent data
shows that astrocyte function can be modulated by deep
brain stimulation (DBS), a non-pharmacological antidepressant
intervention. DBS is an invasive brain stimulation technique
considered as a new hope in the treatment of several intractable
psychiatric diseases such as major depression (Mayberg et al.,
2005; Puigdemont et al., 2015). Current research is mainly
focused on the effects of DBS on neurons, i.e., how myelinated
and unmyelinated axons, dendrites and neuronal cell bodies
respond to DBS (Mcintyre et al., 2004; Gubellini et al., 2009).
However, the role of astrocytes in this context has not yet been
addressed. Several arguments support the view that the effects of
DBS can, at least in part, be mediated by astrocytes acting on
neuronal networks (for review, Vedam-Mai et al., 2012). First,
it is well known that DBS modulates regional blood flow in
the stimulated area, an effect that can be considered as a direct
manifestation of changes in astrocytic activity (Kefalopoulou
et al., 2010). Second, astrocytes can be directly activated by
high frequency stimulation, leading to a rapid Ca2+ increase
(Kang et al., 1998; Serrano et al., 2006, 2008). Third, high
frequency stimulation of primary astrocytes in vitro results in
calcium waves and release of glutamate and ATP (Tawfik et al.,
2010). Accordingly, Bekar et al. (2008) have shown in vitro
that DBS was associated with an increase of ATP outflow
within the thalamus, resulting in an accumulation of adenosine,
which in turn depressed excitatory transmission through A1
receptors activation. The authors proposed that, once present
in the synaptic cleft, adenosine would activate post-synaptic A1
receptors positively coupled to K+ channels and pre-synaptic A1
receptors negatively associated with Ca2+ channels. Both actions
would result in the inhibition of neuronal communication
(Pascual et al., 2005).
Our recent investigations suggest that astrocytes are deeply
involved in the antidepressant-like effects of DBS in rats. The
antidepressant response induced by DBS in humans can be
modeled in rats by stimulating the infralimbic part of the
prefrontal cortex (IL-PFC). It has been shown that acute DBS
produced an antidepressant-like effect in the forced swim test
(Etiévant et al., 2015) and that chronic DBS is able to reverse
the depressive-like states observed in Flinders sensitive Line
rats (Rea et al., 2014) or induced by chronic mild stress
(Hamani et al., 2012). Therefore, the antidepressant-like effect
of DBS is associated with the occurrence of in vivo pre-clinical
markers (Etiévant et al., 2015). We showed that acute DBS
induced a rapid increase of hippocampal neurogenesis, reversed
the effects of stress on hippocampal synaptic metaplasticity,
increased spontaneous IL-PFC low-frequency oscillations and
both raphe 5-HT firing activity and synaptogenesis. Significantly,
we demonstrated that DBS-induced neural adaptations are
strongly altered by pharmacological ablation of astrocytes within
the site of stimulation (IL-PFC). Glial lesion with the gliotoxin
L-alpha amino-adipic acid (L-AAA) counteracted the behavioral
effect of high frequency DBS in the forced swim test and all above
cited markers of the antidepressant response. We also found that
DBS-induced antidepressant-like response was prevented by IL-
PFC neuronal lesion and gap junction blockade as well as by
adenosine A1 receptor antagonists including caffeine.
An elegant review discussing the role of astrocytes in
the effects of DBS (Vedam-Mai et al., 2012) recently raised
the hypothesis that astrocytes, once activated by electrical
stimulation, would release ATP and glutamate leading to an
inhibition or an excitation of synaptic transmission, respectively.
Recent data partially supports this hypothesis and offers further
insights. Our in vivo electrophysiological results revealed that
the astroglial modulation of DBS involved mechanisms related
to changes in adenosine A1 receptor function, together with
the elevation of extracellular K+ concentration (Etiévant et al.,
2015). Our results further showed that the enhancing effect
of bilateral DBS on 5-HT neuronal activity was potentiated
by a selective A1 receptor agonist, unilaterally infused during
the stimulation. This result, together with the fact that the
A1 receptor antagonist DPCPX prevents the antidepressant-like
effect of DBS in the forced swim test, indicates that the efficacy
of DBS partially depends on adenosine A1 receptor stimulation.
Interestingly, recent studies aimed to characterize the role played
by A1 receptors in the shape of action potentials and the
regulation of axonal conductance report that the administration
of an adenosine antagonist increases the width of axonal action
potentials. This result suggests that astrocytes, through the
release of adenosine and subsequent A1 receptor stimulation,
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 January 2016 | Volume 9 | Article 509
Adeline et al. Astrocytes and DBS Antidepressant Response
FIGURE 1 | Proposed hypotheses regarding the involvement of
astrocytes in the effects of DBS. Once activated by DBS, astrocytes
communicate with neurons at the synapse level and regulate the effects of
DBS. Astrocytes, by releasing glutamate (Glu), stimulate neuronal synaptic
release and contribute to the activation of post-synaptic receptors (in green).
ATP is rapidly hydrolyzed into adenosine, which increases the stimulation of
adenosine A1 receptors (A1R) and, in turn, results in a K
+ channel-mediated
reduction of the late hyperpolarization phase of action potentials (in red).
Ultimately, the resulting temporal shrinkage of action potentials (AP width) may
help the neuron to sustain the high frequency demand related to IL-DBS.
Astrocytes also maintain K+ homeostasis, by actively pumping K+ ions from
the extracellular level thus preventing their accumulation due to neuronal
activity (in blue). Modified from Etiévant et al. (2015).
are able to modulate the shape of axonal action potentials,
shortening the total duration of the spike and “shrinking” its
shape (Sasaki et al., 2011). This latter effect could be due to
a modulation of the voltage-activated K+ channels responsible
for neuronal after hyperpolarization. It has been proposed
that such a “temporal shrinking” of action potentials can be
beneficial when the neuron is solicited in response to high-
frequency stimulations, allowing to sustain bursting activity that
requires very short inter-spike intervals (Sasaki et al., 2011).
Thus, we have proposed that a loss of astrocytes within the
site of stimulation induces a drop of adenosine extracellular
concentrations and an altered temporal shrinking of action
potentials responsible for the alteration of the neurobiological
effects of DBS (Figure 1).
Since astrocytes are able to maintain the potassium
homeostasis by actively pumping K+ ions from the extracellular
space (Kofuji and Newman, 2004), we hypothesized that an
alteration of astrocyte function within the lesioned site leads
to an accumulation of extracellular K+ which, in turn, would
produce a depolarization of neuron membrane and a blockade of
DBS-mediated effects. Hence in our in vivo study, a K+-enriched
aCSF was perfused within the IL-PFC using reverse dialysis
while recording 5-HT neurons. The obtained results confirmed
our hypothesis of a “ceiling effect,” related to a K+-dependent
depolarization of pyramidal neurons, since high frequency DBS
is unable to further affect 5-HT activity in the presence of high
[K+]. Thus, the depolarizing action of an elevated extracellular
[K+] potentially impairs the ability of pyramidal cells to respond
to the phasic, high-frequency solicitation demands of sustained
electrical stimulations of 130Hz. This effect is frequency-
dependent since both the 5-HT-activating and the behavioral
effectiveness in the forced swim test of a 30Hz DBS remained
unaltered in glial-lesioned rats and in high [K+] conditions.
This result strongly suggests that, in the absence of astrocytes,
the depolarization of neuronal membrane related to K+
accumulation fails to reach a supra-threshold, “depolarization
block-like” level, and that pyramidal neurons are still able to
follow a low frequency DBS (30Hz; Etiévant et al., 2015).
CONCLUSION
The astroglial system plays a crucial role in the mechanisms
of action of DBS. Accordingly, the antidepressant-like response
induced by DBS is counteracted by a pharmacological lesion of
astrocytes in the stimulated area. Two mechanistic hypotheses
have been proposed to explain the astrocytic modulation of
the neuronal response induced by DBS (Figure 1). First, the
“shrinking hypothesis” suggests that astrocytes, by releasing
adenosine in response to DBS, activate neuronal A1 receptors
resulting in a shortening of the width of action potentials.
Second, the “ceiling hypothesis” proposes that astrocytes,
by actively pumping K+ ions from the extracellular spaces,
prevent the establishment of the “depolarization-like blockade”
of the neuronal membrane. Both events are directed to an
optimal functioning of pyramidal neurons that are still capable
of following high frequency stimulations induced by DBS.
Lastly as a translational outcome, we have proposed that an
unaltered neuronal–glial system constitutes a major prerequisite
to optimize antidepressant DBS efficacy, and that decreasing the
frequency of DBS would increase the antidepressant response of
partial responders.
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